Aligned Bio Revenue and Competitors
Estimated Revenue & Valuation
- Aligned Bio's estimated annual revenue is currently $2.1M per year.
- Aligned Bio's estimated revenue per employee is $121,200
Employee Data
- Aligned Bio has 17 Employees.
- Aligned Bio grew their employee count by -11% last year.
Aligned Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Process Engineer | Reveal Email/Phone |
Aligned Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $45.3M | 204 | 1% | N/A | N/A |
#2 | $54.3M | 250 | -20% | N/A | N/A |
#3 | $108.6M | 768 | 18% | N/A | N/A |
#4 | $8.8M | 87 | 7% | N/A | N/A |
#5 | $15.9M | 143 | 3% | N/A | N/A |
#6 | $10.2M | 101 | 7% | N/A | N/A |
#7 | $3.2M | 40 | 5% | N/A | N/A |
#8 | $15.8M | 142 | 8% | N/A | N/A |
#9 | $19.2M | 95 | 6% | $125.1M | N/A |
#10 | $21.6M | 107 | 8% | N/A | N/A |
What Is Aligned Bio?
Advanced customizable nanowire based sensor platforms for the biosensor and electronics industries.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.1M
Revenue (est)
-11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aligned Bio News
2022-04-20 - BioConnects creates partnership for life sciences racial ...
... the Ignite platform is especially aligned with the mission of BioConnects ... including Latinos in Bio, which helps create opportunities for Hispanic...
2022-04-17 - Akron Bio debuts new plasmid DNA plant on quest to ease ...
Akron is keeping its plant investment close to the vest, though it said [c]osts are aligned with those for construction of a full cGMP facility....
2022-04-06 - Bluebird Bio Has Serious Cash Flow Concerns; Inability To Strike
Reimbursement Deals In Europe Partly To Blame
But that presumes that the price bluebird bio demanded aligns with the value provided by the therapies. As we know from many new therapies,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 17 | -23% | N/A |
#2 | $1.5M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |